This past Tuesday, ODJFS Director Matt Damschroder announced a sliding scale to allow recipients to move off the program gradually. That way, recipients will feel less as though they need to turn down ...

Type 2 diabetes occurs when the body does not make enough insulin or use it correctly. Some people require insulin or other medication, while others can manage blood sugar levels through diet and ...

Chart.js module for adding a new categorical scale which mimics a hierarchical tree. The ESM build of the library supports tree shaking thus having no side effects. As a consequence the chart.js ...

Sliding patio doors typically cost between $1,254 and $2,845 for the door only. Labor costs for installing sliding patio doors range from $264 to $548 per door. Aluminum and vinyl are among the ...

Investors are waiting for an antitrust lawsuit against Visa. Visa has monopoly-like market share and profits in the payment processing industry. The Department of Justice is expected to file a ...

This paper focuses on three fundamental network measurement tasks: membership query, frequency query, and heavy hitter query. Existing solutions, such as sketches, sliding window algorithms, and the ...

which are negotiated with drug manufacturers and are tied to a drug’s list price. Insulin products with higher list prices result in higher rebates and fees for the PBMs, the complaint alleges.

The FTC accused the companies of creating a “perverse” drug rebate system that prioritizes insulin from manufacturers sold at a higher list price even when cheaper versions are available.

That artificially raised the list price of insulin, creating what the agency characterized as a "drug rebate system that prioritizes high rebates" from drugmakers, the FTC alleged in announcing ...

"Insulin is an extreme case of PBMs extracting bigger and bigger rebates from drug manufacturers and driving list prices up at the pharmacy counter, but this is a dynamic that plays out with many ...

The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their position as middlemen in the U.S ...

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices. The FTC accused the "Big Three" pharmacy benefit managers (PBMs ...